These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37155355)

  • 1. Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation.
    Silbernagel G; Chen YQ; Rief M; Kleber ME; Hoffmann MM; Stojakovic T; Stang A; Sarzynski MA; Bouchard C; März W; Qian YW; Scharnagl H; Konrad RJ
    Eur Heart J; 2023 Jul; 44(25):2335-2345. PubMed ID: 37155355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
    Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
    J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL.
    Larsson M; Allan CM; Jung RS; Heizer PJ; Beigneux AP; Young SG; Fong LG
    J Lipid Res; 2017 Sep; 58(9):1893-1902. PubMed ID: 28694296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
    Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
    Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of guinea pig nascent very low density lipoproteins catalyzed by lipoprotein lipase: activation by hjman apolipoprotein C-II.
    Fitzharris TJ; Quinn DM; Goh EH; Johnson JD; Kashyap ML; Srivastava LS; Jackson RL; Harmony JA
    J Lipid Res; 1981 Aug; 22(6):921-33. PubMed ID: 7276752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
    Wang CS; McConathy WJ; Kloer HU; Alaupovic P
    J Clin Invest; 1985 Feb; 75(2):384-90. PubMed ID: 3973011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.
    Wolska A; Lo L; Sviridov DO; Pourmousa M; Pryor M; Ghosh SS; Kakkar R; Davidson M; Wilson S; Pastor RW; Goldberg IJ; Basu D; Drake SK; Cougnoux A; Wu MJ; Neher SB; Freeman LA; Tang J; Amar M; Devalaraja M; Remaley AT
    Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
    Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
    J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach.
    Reimund M; Wolska A; Risti R; Wilson S; Sviridov D; Remaley AT; Lookene A
    Biochem Biophys Res Commun; 2019 Oct; 519(1):67-72. PubMed ID: 31477272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II.
    Meyers NL; Larsson M; Olivecrona G; Small DM
    J Biol Chem; 2015 Jul; 290(29):18029-18044. PubMed ID: 26026161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III.
    McConathy WJ; Gesquiere JC; Bass H; Tartar A; Fruchart JC; Wang CS
    J Lipid Res; 1992 Jul; 33(7):995-1003. PubMed ID: 1431591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.
    Aalto-Setälä K; Weinstock PH; Bisgaier CL; Wu L; Smith JD; Breslow JL
    J Lipid Res; 1996 Aug; 37(8):1802-11. PubMed ID: 8864964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
    MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
    Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase.
    McIlhargey TL; Yang Y; Wong H; Hill JS
    J Biol Chem; 2003 Jun; 278(25):23027-35. PubMed ID: 12682050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.
    Wolska A; Dunbar RL; Freeman LA; Ueda M; Amar MJ; Sviridov DO; Remaley AT
    Atherosclerosis; 2017 Dec; 267():49-60. PubMed ID: 29100061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
    J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.